| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |